IDEXX Laboratories valuation
Valuation
The P/E ratio is 47.0. The average price target of 12 analysts is $717.17.
Data as of November 16, 2026
IDEXX Laboratories compared with similar companies
IDEXX Laboratories's P/E (trailing 12 months): 47.0, +30% against the median of a group of 9 similar companies (36.1).
| Metric | IDEXX Laboratories | Median | 25th–75th percentile | Band |
|---|---|---|---|---|
| P/E (trailing 12 months) | 47.0 | 36.1 | 32.3 – 38.0 | High |
| Forward P/E | 41.7 | 27.8 | 21.7 – 33.5 | High |
| EV/EBITDA | 33.6 | 28.0 | 18.5 – 28.5 | High |
| Price/book | 29.7 | 8.33 | 4.45 – 28.4 | High |
| Price/sales | 11.9 | 6.90 | 4.56 – 13.9 | Middle |
| Gross margin | 62.7% | 59.2% | 43.4% – 65.2% | Middle |
| Operating margin | 32.5% | 16.0% | 12.5% – 23.0% | High |
| Net margin | 25.4% | 9.5% | 4.3% – 19.6% | High |
| ROE | 68.9% | 21.0% | 6.3% – 50.7% | High |
| Debt/equity | 0.52 | 0.56 | 0.33 – 0.78 | Middle |
Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.
TickerLandia analysisHow it is calculated
Companies in the group: same industry, similar size
IDEXX Laboratories: valuation over time
On the latest fiscal year's earnings (2025), IDEXX Laboratories's P/E today is 54.1, in line with the median of its last 10 fiscal years (52.5; between 38.7 and 76.6 from 2016 to 2025). Relative to earnings, it costs about the same as in the past.
| Fiscal year | Price at year end | Earnings per share | P/E |
|---|---|---|---|
| 2025 | $676.53 | $13.08 | 51.7 |
| 2024 | $413.44 | $10.67 | 38.7 |
| 2023 | $555.05 | $10.06 | 55.2 |
| 2022 | $407.96 | $8.03 | 50.8 |
| 2021 | $658.46 | $8.60 | 76.6 |
| 2020 | $499.87 | $6.71 | 74.5 |
| 2019 | $261.13 | $4.89 | 53.4 |
| 2018 | $186.02 | $4.26 | 43.7 |
| 2017 | $156.38 | $2.94 | 53.2 |
| 2016 | $117.27 | $2.44 | 48.1 |
TickerLandia calculation: closing price on the last trading day of the fiscal year divided by diluted earnings per share from the annual report (positive earnings only). Prices adjusted for splits. Today's P/E is today's price divided by the latest fiscal year's earnings per share, so it compares with the years above.
TickerLandia analysisHow it is calculated
Other metrics
Valuation multiples
- Market cap
- $55.48B
- Enterprise value
- $56.26B
- PEG
- 3.27
- EV/revenue
- 12.1
Profitability and growth
- ROA
- 26.7%
- ROIC
- 33.9%
- Revenue growth (year over year)
- 9.9%
- Earnings growth (year over year)
- 17.9%
Financial health
- Total cash
- $197.54M
- Total debt
- $972.96M
- Current ratio
- 1.19
- Quick ratio
- 0.73
- Altman Z-Score
- 21.2
- Piotroski F-Score
- 8.00
Dividends
- Dividend yield
- 0.0%
- Payout ratio
- 0.0%
Analysts and estimates
- Average price target
- $717.17
- Median price target
- $717.50
- High price target
- $810.00
- Low price target
- $470.00
- Analysts with a price target
- 12
- Consensus
- Buy
- Forward EPS
- $16.89
- EPS estimate, current year
- $15.02
Shares and trading
- Beta
- 1.54
- Average volume
- 568.56K
- Shares outstanding
- 78.79M
- Float
- 78.51M
- Institutional ownership
- 94.6%
- Insider ownership
- 0.7%
- Short interest (% of float)
- 3.4%
- Short ratio (days)
- 4.38
